Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients during the 2013 and 2014 Influenza Season in Beijing

Microbial Drug Resistance

Volumn 23, Issue 2, 2017, Pages 253-260

  Li, Xiaodong ^a   Liao, Hao ^a,b   Liu, Yan ^a   Liu, Liming ^a   Wang, Fusheng ^a   Song, Hongbin ^c   Cheng, Jun ^d   Liu, Xinguang ^b   Xu, Dongping ^a  

^a BEIJING 302 HOSPITAL   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; HEMAGGLUTININ; INFLUENZA VACCINE; MATRIX PROTEIN; OSELTAMIVIR; PERAMIVIR; SIALIDASE; ZANAMIVIR; ANTIVIRUS AGENT; VIRAL PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC SIMILARITY; HUMAN; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA A VIRUS; INFLUENZA B VIRUS; NOSE SMEAR; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN; DRUG EFFECTS; GENETICS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; MOLECULAR EVOLUTION; PHYLOGENY; SEASON; VIROLOGY;

ANTIVIRAL AGENTS; BEIJING; DRUG RESISTANCE, VIRAL; EVOLUTION, MOLECULAR; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NEURAMINIDASE; PHYLOGENY; SEASONS; VIRAL PROTEINS;

EID: 85015084623     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0297     Document Type: Article

References (26)

1. Tong, S., X. Zhu, Y. Li, M. Shi, J. Zhang, M. Bourgeois, H. Yang, X. Chen, S. Recuenco, J. Gomez, L.M. Chen, A. Johnson, Y. Tao, C. Dreyfus, W. Yu, R. McBride, P.J. Carney, A.T. Gilbert, J. Chang, Z. Guo, C.T. Davis, J.C. Paulson, J. Stevens, C.E. Rupprecht, E.C. Holmes, I.A. Wilson, and R.O. Donis. 2013. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9:e1003657.
2. Yoon, S.W., R.J. Webby, and R.G. Webster. 2014. Evolution and ecology of influenza A viruses. Curr. Top. Microbiol. 385:359-375.
3. Rota, P.A., T.R. Wallis, M.W. Harmon, J.S. Rota, A.P. Kendal, and K. Nerome. 1990. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59-68.
4. Chen, R., and E.C. Holmes. 2008. The evolutionary dynamics of human influenza B virus. J. Mol. Evol. 66:655-663.
5. Dapat, C., H. Kondo, I.C. Dapat, T. Baranovich, Y. Suzuki, Y. Shobugawa, K. Saito, R. Saito, and H. Suzuki. 2013. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan. Antiviral Res. 99:261-269.
6. Jian, J.W., C.T. Lai, C.Y. Kuo, S.H. Kuo, L.C. Hsu, P.J. Chen, H.S. Wu, and M.T. Liu. 2008. Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics. Virus Res. 131:243-249.
7. Nguyen, H.T., A.M. Fry, and L.V. Gubareva. 2012. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antiviral Ther. 17:159-173.
8. Wang, J., Y. Wu, C. Ma, G. Fiorin, J. Wang, L.H. Pinto, R.A. Lamb, M.L. Klein, and W.F. Degrado. 2013. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 110:1315-1320.
9. Wu, Y., B. Canturk, H. Jo, C. Ma, E. Gianti, M.L. Klein, L.H. Pinto, R.A. Lamb, G. Fiorin, J. Wang, and W.F. DeGrado. 2014. Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wildtype versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel. J. Am. Chem. Soc. 136:17987-17995.
10. Garcia, V., and S. Aris-Brosou. 2014. Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors. Mol. Biol. Evol. 31:355-363.
11. Ikematsu, H., N. Kawai, N. Iwaki, and S. Kashiwagi. 2014. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan. J. Infect. Chemother. 20:77-80.
12. Takashita, E., A. Meijer, A. Lackenby, L. Gubareva, H. Rebelo-de-Andrade, T. Besselaar, A. Fry, V. Gregory, S.K. Leang, W. Huang, J. Lo, D. Pereyaslov, M.M. Siqueira, D. Wang, G.C. Mak, W. Zhang, R.S. Daniels, A.C. Hurt, and M. Tashiro. 2015. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antiviral Res. 117:27-38.
13. Zhong, J., L. Liang, P. Huang, X. Zhu, L. Zou, S. Yu, X. Zhang, Y. Zhang, H. Ni, and J. Yan. 2013. Genetic mutations in influenza H3N2 viruses from a 2012 epidemic in Southern China. Virol. J. 10:345.
14. Zhou, B., M.E. Donnelly, D.T. Scholes, G.K. St, M. Hatta, Y. Kawaoka, and D.E. Wentworth. 2009. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J. Virol. 83:10309-10313.
15. Sheu, T.G., A.M. Fry, R.J. Garten, V.M. Deyde, T. Shwe, L. Bullion, P.J. Peebles, Y. Li, A.I. Klimov, and L.V. Gubareva. 2011. Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses:2008-2010. J. Infect. Dis. 203:13-17.
16. Butler, J., K.A. Hooper, S. Petrie, R. Lee, S. Maurer-Stroh, L. Reh, T. Guarnaccia, C. Baas, L. Xue, S. Vitesnik, S.K. Leang, J. McVernon, A. Kelso, I.G. Barr, J.M. McCaw, J.D. Bloom, and A.C. Hurt. 2014. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog. 10:e1004065.
17. Abed, Y., A. Pizzorno, X. Bouhy, C. Rheaume, and G. Boivin. 2014. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivirresistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets. J. Virol. 88:1652-1658.
18. Okomo-Adhiambo, M., H.T. Nguyen, E.A. Abd, K. Sleeman, A.M. Fry, and L.V. Gubareva. 2014. Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria. Influenza Other Respir. Viruses 8:258-265.
19. Huang, W., X. Li, Y. Cheng, M. Tan, J. Guo, H. Wei, X. Zhao, Y. Lan, N. Xiao, Z. Wang, D. Wang, and Y. Shu. 2015. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China. Virol. J. 12:96.
20. Chinese National Influenza Center (CNIC). 2014. Chinese Influenza Weekly Report. Available at www.cnic.org.cn/ eng/show.php?contentid=724 (Online.)
21. Pozo, F., B. Lina, H.R. Andrade, V. Enouf, A. Kossyvakis, E. Broberg, R. Daniels, A. Lackenby, and A. Meijer. 2013. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. J. Clin. Virol. 57:5-12.
22. Kawai, N., H. Ikematsu, N. Hirotsu, T. Maeda, T. Kawashima, O. Tanaka, S. Yamauchi, K. Kawamura, S. Matsuura, M. Nishimura, N. Iwaki, and S. Kashiwagi. 2009. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Clin. Infect. Dis. 49:1828-1835.
23. van der Vries, E., M. Jonges, S. Herfst, J. Maaskant, A.van der Linden, J. Guldemeester, G.I. Aron, T.M. Bestebroer, M. Koopmans, A. Meijer, R.A. Fouchier, A.D. Osterhaus, C.A. Boucher, and M. Schutten. 2010. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 47:34-37.
24. Takashita, E., M. Kiso, S. Fujisaki, M. Yokoyama, K. Nakamura, M. Shirakura, H. Sato, T. Odagiri, Y. Kawaoka, and M. Tashiro. 2015. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob. Agents Chemother. 59:2607-2617.
25. Okomo-Adhiambo, M., A.M. Fry, S. Su, H.T. Nguyen, A.A. Elal, E. Negron, J. Hand, R.J. Garten, J. Barnes, X. Xiyan, J.M. Villanueva, and L.V. Gubareva. 2015. Oseltamivirresistant influenza A(H1N1)pdm09 viruses, United States, 2013-2014. Emerg. Infect. Dis. 21:136-141.
26. Wang, Q., F. Cheng, M. Lu, X. Tian, and J. Ma. 2008. Crystal structure of unliganded influenza B virus hemagglutinin. J. Virol. 82:3011-3020.